All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F18%3A10383541" target="_blank" >RIV/00216208:11130/18:10383541 - isvavai.cz</a>

  • Alternative codes found

    RIV/00064203:_____/18:10383541

  • Result on the web

    <a href="https://doi.org/10.1080/2162402X.2018.1503032" target="_blank" >https://doi.org/10.1080/2162402X.2018.1503032</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1080/2162402X.2018.1503032" target="_blank" >10.1080/2162402X.2018.1503032</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors

  • Original language description

    Oncolytic viruses selectively target and kill cancer cells in an immunogenic fashion, thus supporting the establishment of therapeutically relevant tumor-specific immune responses. In 2015, the US Food and Drug Administration (FDA) approved the oncolytic herpes simplex virus T-VEC for use in advanced melanoma patients. Since then, a plethora of trials has been initiated to assess the safety and efficacy of multiple oncolytic viruses in patients affected with various malignancies. Here, we summarize recent preclinical and clinical progress in the field of oncolytic virotherapy.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30102 - Immunology

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2018

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    OncoImmunology [online]

  • ISSN

    2162-402X

  • e-ISSN

  • Volume of the periodical

    7

  • Issue of the periodical within the volume

    12

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    32

  • Pages from-to

  • UT code for WoS article

    000450462000017

  • EID of the result in the Scopus database

    2-s2.0-85058014194